Psychedelic Alpha News Feed covering January 5 to June 1, 2025: weekly round-ups of psychedelics news

Psychedelic Alpha compiles a weekly news digest of major developments in the psychedelics field from January 2025 through June 1, 2025. Coverage centers on the policy and regulatory environment, including state decriminalization efforts, licensing for psychedelic therapy facilitators, and federal-level shifts that affect funding and oversight. The digest also tracks corporate and investment activity, with updates on major stakeholders and company strategy changes. Research and clinical pipeline items are repeatedly highlighted, including progress and setbacks across psychedelic-assisted therapies and related trials. Specific substances mentioned across entries include psilocybin, MDMA, ketamine, DMT, ibogaine, and amanita (along with other or unspecified psychedelics).